Company intelligence / Profile preview

FINAO Biotech

Portalegre*, Portalegre, Portugalfinaobiotech.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

The company offers a commercial line of wound care products under the Mesitran brand. No clinical trial data or results are publicly available for novel therapeutics. Focus appears to be on distribution and commercialization rather than drug discovery/development at this time.

Therapeutic areas: Dermatology
Modalities: Medical devices (wound care products such as gels, ointments, dressings)Pharmaceuticals (drugs and proprietary medicines)Cosmetics and food supplements
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on FINAO Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FINAO Biotech.

Explore the full profile